(Q50335791)

5 March 2018

title

The factor V activation paradox. (English)

1 reference

5 March 2018

author name string

Thomas Orfeo

1

1 reference

5 March 2018

Nicole Brufatto

2

1 reference

5 March 2018

Michael E Nesheim

3

1 reference

5 March 2018

Hung Xu

4

1 reference

5 March 2018

Saulius Butenas

5

1 reference

5 March 2018

Kenneth G Mann

6

1 reference

5 March 2018

language of work or name

English

0 references

publication date

24 February 2004

1 reference

5 March 2018

Journal of Biological Chemistry

number of pages

12

1 reference

based on heuristic

inferred from page(s)

published in

1 reference

5 March 2018

volume

279

1 reference

5 March 2018

issue

19

1 reference

5 March 2018

page(s)

19580-19591

1 reference

5 March 2018

The dynamics of thrombin formation

cites work

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M400727200

Increased tissue factor-initiated prothrombin activation as a result of the Arg506 --> Gln mutation in factor VLEIDEN

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M400727200

A model for the stoichiometric regulation of blood coagulation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M400727200

Blood coagulation at the site of microvascular injury: effects of low-dose aspirin

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M400727200

Factor V: a combination of Dr Jekyll and Mr Hyde

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M400727200

Complete cDNA and derived amino acid sequence of human factor V

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M400727200

Structural requirements for expression of factor Va activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M400727200

Thrombin-catalyzed activation of recombinant human factor V.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M400727200

The mechanism of activation of bovine prothrombin by an activator isolated from Echis carinatus venon and characterization of the new active intermediates

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M400727200

Isolation of functional human coagulation factor V by using a hybridoma antibody

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M400727200

Progressive development of a thrombin inhibitor binding site.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M400727200

Interactions of a fluorescent active-site-directed inhibitor of thrombin: dansylarginine N-(3-ethyl-1,5-pentanediyl)amide

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M400727200

Geometric packing constraints in egg phosphatidylcholine vesicles

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M400727200

Equilibria involved in prothrombin- and blood-clotting factor X-membrane binding

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M400727200

Cleavage of Structural Proteins during the Assembly of the Head of Bacteriophage T4

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M400727200

Silver stain for proteins in polyacrylamide gels: A modified procedure with enhanced uniform sensitivity

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M400727200

Autocatalytic peptide bond cleavages in prothrombin and meizothrombin.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M400727200

Analysis of the kinetics of prothrombin activation and evidence that two equilibrating forms of prothrombinase are involved in the process

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M400727200

Predicting the pharmacology of thrombin inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M400727200

Evaluation of the initiation phase of blood coagulation using ultrasensitive assays for serine proteases

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M400727200

Thrombin functions during tissue factor-induced blood coagulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M400727200

Activation of human factor V by factor Xa and thrombin

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M400727200

Proteolysis of factor V by cathepsin G and elastase indicates that cleavage at Arg1545 optimizes cofactor function by facilitating factor Xa binding

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M400727200

The role of the membrane in the inactivation of factor va by plasmin. Amino acid region 307-348 of factor V plays a critical role in factor Va cofactor function

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M400727200

Cathepsin G activates human factor V in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M400727200

Functional characterization of recombinant human meizothrombin and Meizothrombin(desF1). Thrombomodulin-dependent activation of protein C and thrombin-activatable fibrinolysis inhibitor (TAFI), platelet aggregation, antithrombin-III inhibition

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M400727200

Aminonaphthalenesulfonamides, a new class of modifiable fluorescent detecting groups and their use in substrates for serine protease enzymes

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M400727200

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M400727200

A model describing the inactivation of factor Va by APC: bond cleavage, fragment dissociation, and product inhibition

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M400727200

Cleavage requirements for activation of factor V by factor Xa

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M400727200

Thrombin-mediated proteolysis of factor V resulting in gradual B-domain release and exposure of the factor Xa-binding site

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M400727200

Evidence that meizothrombin is an intermediate product in the clotting of whole blood

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M400727200

21 January 2018

Identifiers

DOI

10.1074/JBC.M400727200

1 reference

5 March 2018

PubMed ID

14982929

1 reference

5 March 2018